Skip to content

Studying the effectiveness of moderate-intensity aerobic exercise on metabolic syndrome

Studying the effectiveness of moderate-intensity aerobic exercise on anthropometric criteria, carotid intima-media thickness, nonalcoholic fatty liver disease, and metabolic profile of patients with metabolic syndrome referred to the clinic of Loghman Hakim Hospital

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20251021067713N1
Enrollment
40
Registered
2025-12-09
Start date
2025-11-22
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome. Metabolic syndrome

Interventions

Intervention 1: Intervention group: 24 sessions of exercise therapy are performed three times a week under the supervision of a physician. The intensity of the exercise is adjusted based on the patien

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: People who have 3 or more of the metabolic syndrome criteria Elevated Waist Circumference: Men>102cm ,Women >88cm Elevated Triglycerides =150mg/dl or on drug treatment Reduced HDL: Men<40 ,Women<50 or on drug treatment Elevated Blood Pressure: Systolic=130 and/or Diastolic=85 or on drug treatment Elevated Fasting Glucose = 100mg/dl or on drug treatment

Exclusion criteria

Exclusion criteria: Individuals who take blood sugar lowering medications Alcohol users Individuals with psychiatric conditions Individuals with musculoskeletal problems who are unable to exercise Individuals who are absent from more than two consecutive exercise sessions Individuals who are engaged in professional sport 40160 mg/dL along with cardiovascular disease risk LDL>190 Patients with ischemic heart disease

Design outcomes

Primary

MeasureTime frame
Liver steatosis grade. Timepoint: First study and after completing 8 weeks of intervention. Method of measurement: Ultrasonography.;Carotid Intima-Media Thickness (CIMT). Timepoint: First study and after completing 8 weeks of intervention. Method of measurement: Ultrasoography.;Skeletal Muscle Mass. Timepoint: Firs study and after completing 8 weeks of intervention. Method of measurement: Body Composition Analyzer.;Percent Body Fat. Timepoint: Firs study and after completing 8 weeks of intervention. Method of measurement: Body Composition Analyzer.;Body Mass Index. Timepoint: Firs study and after completing 8 weeks of intervention. Method of measurement: Body Composition Analyzer.;Waist/hip ratio. Timepoint: Firs study and after completing 8 weeks of intervention. Method of measurement: Body Composition Analyzer.;Body Fat Mass. Timepoint: Firs study and after completing 8 weeks of intervention. Method of measurement: Body Composition Analyzer.;Visceral Fat Level. Timepoint: Firs study and after completing 8 weeks of intervention. Method of measurement: Body Composition Analyzer.;Lipid profile. Timepoint: Firs study and after completing 8 weeks of intervention. Method of measurement: Blood Test.;Thyroid-Stimulating Hormone. Timepoint: Firs study and after completing 8 weeks of intervention. Method of measurement: Blood Test.;Liver Function Test(s). Timepoint: Firs study and after completing 8 weeks of intervention. Method of measurement: Blood Test.;Fasting Blood Suger. Timepoint: Firs study and after completing 8 weeks of intervention. Method of measurement: Blood Test.;Glycated Hemoglobin. Timepoint: Firs study and after completing 8 weeks of intervention. Method of measurement: Blood Test.;Blood pressure. Timepoint: Firs study and after completing 8 weeks of intervention. Method of measurement: Blood Pressure Monitor.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZohreh Pourhassan

Shahid Beheshti University of Medical Sciences

afsaneh.saffarian@sbmu.ac.ir+98 21 5541 9005

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 7, 2026